Dale B. Evans

1.5k total citations
31 papers, 1.2k citations indexed

About

Dale B. Evans is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, Dale B. Evans has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 7 papers in Organic Chemistry. Recurrent topics in Dale B. Evans's work include Phosphodiesterase function and regulation (6 papers), Enzyme function and inhibition (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Dale B. Evans is often cited by papers focused on Phosphodiesterase function and regulation (6 papers), Enzyme function and inhibition (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Dale B. Evans collaborates with scholars based in United States, Malaysia and Sweden. Dale B. Evans's co-authors include Ronald E. Weishaar, James A. Bristol, Ila Sircar, Mary Quade, Stephen D. Burrows, Paul J. Silver, Robert J. Laffan, Ross Bentley, L T Hamel and Robert J. Lee and has published in prestigious journals such as Journal of Medicinal Chemistry, The American Journal of Cardiology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Dale B. Evans

30 papers receiving 1.1k citations

Peers

Dale B. Evans
Adawia A. Alousi United States
G. P�ch Austria
A. Farah United States
Elke Stahl Germany
Yumiko Shibouta Japan
Ronald E. Weishaar United States
Akio Kiyomoto United States
Wolfgang Klaus Germany
R. H. A. Becker Germany
Donald G. Gardiner United Kingdom
Adawia A. Alousi United States
Dale B. Evans
Citations per year, relative to Dale B. Evans Dale B. Evans (= 1×) peers Adawia A. Alousi

Countries citing papers authored by Dale B. Evans

Since Specialization
Citations

This map shows the geographic impact of Dale B. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dale B. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dale B. Evans more than expected).

Fields of papers citing papers by Dale B. Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dale B. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dale B. Evans. The network helps show where Dale B. Evans may publish in the future.

Co-authorship network of co-authors of Dale B. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Dale B. Evans. A scholar is included among the top collaborators of Dale B. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dale B. Evans. Dale B. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evans, Dale B.. (1989). Overview of cardiovascular physiologic and pharmacologic aspects of selective phosphodiesterase peak III inhibitors. The American Journal of Cardiology. 63(2). A9–A11. 36 indexed citations
2.
3.
Harris, Alex L., Alison M. Grant, Paul J. Silver, Dale B. Evans, & Adawia A. Alousi. (1989). Differential Vasorelaxant Effects of Milrinone and Amrinone on Contractile Responses of Canine Coronary, Cerebral, and Renal Arteries. Journal of Cardiovascular Pharmacology. 13(2). 238–244. 38 indexed citations
4.
Silver, Paul J., Alex L. Harris, Paul C. Canniff, et al.. (1989). Phosphodiesterase Isozyme Inhibition, Activation of the cAMP System, and Positive Inotropy Mediated by Milrinone in Isolated Guinea Pig Cardiac Muscle. Journal of Cardiovascular Pharmacology. 13(4). 530–540. 48 indexed citations
5.
Harris, Alex L., et al.. (1988). The vasorelaxant effects of milrinone and other vasodilators are attenuated by ouabain. European Journal of Pharmacology. 145(2). 133–139. 7 indexed citations
6.
Silver, Paul J., et al.. (1988). Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle. European Journal of Pharmacology. 150(1-2). 85–94. 97 indexed citations
7.
Feld, William A., et al.. (1987). The Synthesis of 5- and 6-Formyl-1-ethoxy-1,2,3-benzotriazole. Heterocycles. 26(6). 1569–1569.
8.
Evans, Dale B., et al.. (1986). Cardiovascular pharmacology of the cardiotonic, imazodan (Cl‐914). Drug Development Research. 9(2). 143–157. 8 indexed citations
9.
Evans, Dale B.. (1986). Modulation of cAMP. Journal of Cardiovascular Pharmacology. 8. S22–29. 36 indexed citations
10.
Evans, Dale B.. (1986). Modulation of cAMP. Journal of Cardiovascular Pharmacology. 8. S22–29. 38 indexed citations
11.
Weishaar, Ronald E., et al.. (1986). Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Biochemical Pharmacology. 35(5). 787–800. 216 indexed citations
12.
Sircar, Ila, et al.. (1986). Cardiotonic agents. 3. Synthesis and biological activity of novel 6-(substituted 1H-imidazol-4(5)-yl)-3(2H)-pyridazinones. Journal of Medicinal Chemistry. 29(2). 261–267. 16 indexed citations
13.
Steffen, Robert, et al.. (1986). The Effect of the Cardiotonic Imazodan (CI-914) on Myocardial and Peripheral Hemodynamics in the Anesthetized Dog. Journal of Cardiovascular Pharmacology. 8(3). 520–526. 18 indexed citations
14.
Weishaar, Ronald E., et al.. (1985). Studies aimed at elucidating the mechanism of action of CI-914, a new cardiotonic agent. European Journal of Pharmacology. 119(3). 205–215. 34 indexed citations
15.
16.
Cohen, David, Dale B. Evans, Michael J. Ryan, & Harvey Kaplan. (1985). Quinapril. Cardiovascular Drug Reviews. 3(1). 71–84. 2 indexed citations
17.
Evans, Dale B., Charles S. Parham, & Robert J. Laffan. (1979). Non-specific myocardial depression by beta-adrenergic receptor blockers in normal and compromised myocardium.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 240(2). 240–8. 5 indexed citations
18.
Evans, Dale B., et al.. (1978). Correlation of urinary excretion of methadone metabolites with methadone metabolism and analgesia in the rat.. Journal of Pharmacology and Experimental Therapeutics. 204(1). 67–76. 14 indexed citations
19.
Evans, Dale B., et al.. (1976). Anti-arrhythmic action of nadolol, a β-adrenergic receptor blocking agent. European Journal of Pharmacology. 35(1). 17–27. 26 indexed citations
20.
Lee, Robert J., et al.. (1975). Pharmacology of nadolol (SQ 11725), a β-adrenergic antagonist lacking direct myocardial depression. European Journal of Pharmacology. 33(2). 371–382. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adawia A. Alousi Breakdown of academic impact, for papers by G. P�ch Breakdown of academic impact, for papers by A. Farah Breakdown of academic impact, for papers by Elke Stahl Breakdown of academic impact, for papers by Yumiko Shibouta Breakdown of academic impact, for papers by Ronald E. Weishaar Breakdown of academic impact, for papers by Akio Kiyomoto Breakdown of academic impact, for papers by Wolfgang Klaus Breakdown of academic impact, for papers by R. H. A. Becker Breakdown of academic impact, for papers by Donald G. Gardiner
Rankless by CCL
2026